X

Investor News: IsoRay, Inc. (NYSEMKT:ISR) under Investigation over potential Wrongdoing

An investigation for investors in NYSEMKT:ISR shares concerning potential breaches of fiduciary duties by certain IsoRay directors. was announced.

Investors who are current long term investors in IsoRay, Inc. (NYSEMKT:ISR) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 – 1554.

The investigation by a law firm for current long term investors in NYSEMKT:ISR stocks follows a lawsuit filed recently against IsoRay, Inc. over alleged securities laws violations. The investigation on behalf of current long term investors in NYSEMKT:ISR stocks, concerns whether certain IsoRay directors are liable in connection with the allegations made in that lawsuit. The plaintiff alleges that the Defendants allegedly made false and/or misleading statements regarding IsoRay’s Celsium-131 isotope seeds and mesh for the treatment of non-small cell lung cancers and that when the true details entered the market, shares of IsoRay, Inc. (NYSEMKT:ISR) fell $1.10 per share or over 35% to close at $2.02 per share on May 21, 2015, damaging investors.

On May 20, 2015, IsoRay, Inc. announced the on-line publication of the first major peer reviewed study showing improved results using IsoRay’s Cesium-131 seeds in the treatment of lung cancer.

Shares of IsoRay, Inc. (NYSEMKT:ISR) grew from $1.48 per share on May 19, 2015, to as high as $3.79 per share on May 21, 2015. However, on May 21, 2015, an article was published that said that “IsoRay does a poor job selling radioactive ‘seeds’ for use in cancer radiation therapy” and “to make up for the inability to deliver revenue growth — and prop up its stock price”

Shares of IsoRay, Inc. (NYSEMKT:ISR) closed on July 5, 2016 at $0.832 per share.

Those who purchased NYSEMKT:ISR shares have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North – Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com

John:
Related Post